All participants in both groups finished the treatment protocol,
and consequently, all were subjected to post–gait
analysis. Two participants were missing FU gait measures.
One participant in the control group was missing FU measures
because treatment was not interrupted after the 20
sessions of the protocol, and 1 participant in the experimental
group was missing FU measures because of neurological
problems that occurred after the end of treatment and before
the 6-week FU gait analysis (see Figure 1, flow chart). For
the data analysis, their FU data were replaced with their
At baseline there were no significant differences in the
characteristics of the groups, except for time after stroke.
The experimental BFB group had had stroke for a significantly
longer time. See Table 1 for details.
- 8 years agoFavorite Answer